Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
189
NCT00497809
Safety and Efficacy Study of GCSF Therapy to Treat Patients at High Risk for Chemotherapy Induced Severe Neutropenia
Phase: Phase 2
Role: Lead Sponsor
Start: Aug 31, 2007
Completion: Jul 31, 2009